- £1.45bn
- £14.78bn
- £1.03bn
- 55
- 78
- 96
- 91
2019 September 30th | 2020 September 30th | C2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 535 | 509 | 458 | 568 | 1,028 |
Cost of Revenue | |||||
Gross Profit | 310 | 379 | 370 | 455 | 639 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 376 | 390 | 244 | 150 | 828 |
Operating Profit | 159 | 118 | 214 | 418 | 200 |
Net Income Before Taxes | 159 | 118 | 214 | 418 | 200 |
Provision for Income Taxes | |||||
Net Income After Taxes | 127 | 91.3 | 165 | 314 | 154 |
Net Income Before Extraordinary Items | |||||
Net Income | 127 | 91.3 | 165 | 314 | 154 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 127 | 91.3 | 165 | 314 | 154 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.482 | 0.356 | 0.63 | 1.26 | 0.672 |
Dividends per Share |